Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.72%
#2 Ocean Protocol Ocean Protocol +16.95%
#3 KUB Coin KUB Coin +11.80%
#4 Cysic Cysic +11.71%
#5 Perle Perle +11.29%
#6 Arowana Arowana +10.33%
#7 Geodnet Geodnet +9.94%
#8 Wiki Cat Wiki Cat +9.69%
#9 Audiera Audiera +9.23%
#10 DexNet DexNet +7.78%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Classement en actions #32090
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Prix de l'action
$0.21483059
Dernière synchronisation: 2024-05-07
Capitalisation boursière
$11.13M
Changement (1 jour)
0.34%
Changement (1 an)
0.00%
Pays
CA
Échange Antibe Therapeutics Inc. (ATE)

Catégorie

Healthcare
Le prix ATE avec la capitalisation boursière de B
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
ATE
$0.21483059
Capitalisation boursière de Antibe Therapeutics Inc.(ATE)
Capitalisation boursière: $11.13M
En August 2026, Antibe Therapeutics Inc. a une capitalisation boursière de $11.13M. Cela fait de Antibe Therapeutics Inc. la 32090th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Antibe Therapeutics Inc. du 2013 au 2026
ATE par rapport au top 5 des plus populaires stocks
Prix pour ATE L’actif B La capitalisation boursière de B Résultats
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$105,363 $11.13M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.460T +49,044,735.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$86,632.75 $11.13M
Apple Inc. Apple Inc.
AAPL
$4.489T +40,325,975.22%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$79,906.01 $11.13M
Alphabet Inc. Alphabet Inc.
GOOG
$4.141T +37,194,795.68%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$68,861.34 $11.13M
Microsoft Corporation Microsoft Corporation
MSFT
$3.569T +32,053,685.74%
Antibe Therapeutics Inc. Antibe Therapeutics Inc.
$53,993.05 $11.13M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.798T +25,132,751.91%